These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35767128)

  • 41. Molecular modeling studies of novel naphthyridine and isoquinoline derivatives as CDK8 inhibitors.
    Li Q; Feng K; Liu J; Ren Y
    J Biomol Struct Dyn; 2021 Oct; 39(17):6355-6369. PubMed ID: 32723012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of Structural Requirements of N-Substituted Tetrahydro-β-Carboline Imidazolium Salt Derivatives Using in Silico Approaches for Designing MEK-1 Inhibitors.
    Liang J; Wang M; Li X; He X; Cao C; Meng F
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28629184
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of the structural features of quinazoline derivatives as EGFR inhibitors using 3D-QSAR modeling, molecular docking, molecular dynamics simulations and free energy calculations.
    Wang F; Yang W; Liu H; Zhou B
    J Biomol Struct Dyn; 2022; 40(21):11125-11140. PubMed ID: 34338597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations.
    Itteboina R; Ballu S; Sivan SK; Manga V
    J Recept Signal Transduct Res; 2017 Oct; 37(5):453-469. PubMed ID: 28537140
    [TBL] [Abstract][Full Text] [Related]  

  • 47.
    Liu J; Feng K; Ren Y
    J Biomol Struct Dyn; 2019 Sep; 37(14):3803-3821. PubMed ID: 30261821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
    Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3D-QSAR, molecular docking, molecular dynamics, and ADME/T analysis of marketed and newly designed flavonoids as inhibitors of Bcl-2 family proteins for targeting U-87 glioblastoma.
    Poustforoosh A; Faramarz S; Nematollahi MH; Hashemipour H; Tüzün B; Pardakhty A; Mehrabani M
    J Cell Biochem; 2022 Feb; 123(2):390-405. PubMed ID: 34791695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
    Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
    Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CoMFA, CoMSIA and HQSAR Analysis of 3-aryl-3-ethoxypropanoic Acid Derivatives as GPR40 Modulators.
    Gajjar KA; Gajjar AK
    Curr Drug Discov Technol; 2020; 17(1):100-118. PubMed ID: 30160214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular modeling studies of 1,2,4-triazine derivatives as novel h-DAAO inhibitors by 3D-QSAR, docking and dynamics simulations.
    Qian PP; Wang S; Feng KR; Ren YJ
    RSC Adv; 2018 Apr; 8(26):14311-14327. PubMed ID: 35540777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3D-QSAR-aided design of potent c-Met inhibitors using molecular dynamics simulation and binding free energy calculation.
    Balasubramanian PK; Balupuri A; Bhujbal SP; Cho SJ
    J Biomol Struct Dyn; 2019 May; 37(8):2165-2178. PubMed ID: 30044205
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations.
    Zhao J; Zang J; Yang J; Gao QB; Yan Y; Ma C; Chen Y; Ding L; Liu HM
    J Biomol Struct Dyn; 2022 Apr; 40(6):2674-2688. PubMed ID: 33183176
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular modeling studies of benzothiophene-containing derivatives as promising selective estrogen receptor downregulators: a combination of 3D-QSAR, molecular docking and molecular dynamics simulations.
    Zhang C; Li Q; Ren Y; Liu F
    J Biomol Struct Dyn; 2021 May; 39(8):2702-2723. PubMed ID: 32249694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors.
    Zhang G; Ren Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30423939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
    Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.